USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ORBIS BIOSCIENCES, INC.
Address:
2002 W 39th Ave
KANSAS CITY, KS 66013-
Phone:
N/A
URL:
N/A
EIN:
126236030
DUNS:
828536438
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,601,143.00 5
SBIR Phase II $1,698,318.00 1

Award List:

Expanding Precision Particle Fabrication Technology for the Widespread Control of

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$695,173.00
Agency:
HHS
Principal Investigator:
Maria Flynn
Abstract:
DESCRIPTION (provided by applicant): This overall goal of this project is to develop a scalable process for fabricating oil encapsulated particles with uniform sizes and physical characteristics that contain oil as a vehicle for delivering hydrophobic drug s. Poorly water soluble active… More

Multi-day Pain Management Therapy with Novel Injectable Formulation

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$253,678.00
Agency:
HHS
Principal Investigator:
Maria Flynn – 816-223-2662
Abstract:
DESCRIPTION (provided by applicant): Our long term goal is to widespread the use of PPF technology for promoting effective production of drug-encapsulating microparticles with uniform size and physical characteristics that can be leveraged to release a specific drug at controlled rates over… More

First Generation of Controlled-Release Bacteriocins/Anti-Microbials

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$149,216.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
David W. Dumbauld, Business Development Manager – (913) 945-7796
Abstract:
Combat ration Intermediate Moisture (IM) products use low pH and water content (aw) to discourage bacterial growth. The long-term goal of this proposal is to maintain the microbial stability of ration components over a two-year shelf life while increasing the pH and aw values for an improved… More

Precision Particle Fabrication-enabled Betamethasone-loaded Microspheres for Tran

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$287,056.00
Agency:
HHS
Principal Investigator:
Nathan H. Dormer – 816-223-2662
Abstract:
DESCRIPTION (provided by applicant): Current approaches to treat sudden sensorineural hearing loss (SSNHL) do not maintain inner ear drug concentrations within an appropriate therapeutic window for sufficient lengths of time to achieve therapeutic effect.A novel delivery system for long-term,… More

Engineering Microparticles for Taste-Masking and Controlled Release of Pediatric

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$216,020.00
Agency:
HHS
Principal Investigator:
Milind Singh – 785-691-8693
Abstract:
DESCRIPTION (provided by applicant): Pediatric drug development presents many unique challenges in the effective treatment of diseases in children, from adequate dosing information and pediatric-specific testing to palatable flavor profiles and effective delivery formats. A novel technology that… More

Expanding Precision Particle Fabrication Technology for the Widespread Control of

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,698,318.00
Agency:
HHS
Principal Investigator:
Nathan H. Dormer – 913-945-7796
Abstract:
DESCRIPTION (provided by applicant): A critical need currently exists in the pharmaceutical market for microparticles that can accurately and effectively control the release of poorly water-soluble compounds. Although these poorly water-soluble drugs areprojected to have high clinical efficacy,… More